Source: Annual Congress 2001 - Epidemiology of COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Fukuchi, M. Nishimura, M. Ichinose, M. Adachi, A. Nagai, T. Kuriyama, K. Takahashi, K. Nishimura, S. Ishioka, H. Aizawa, A. Iqbal (Tokyo, Hokkaido, Miyagi, Chiba, Ishikawa, Hiroshima, Fukuoka, Japan; Santa Monica, United States Of America). Prevalence of chronic obstructive pulmonary disease in Japan: results from the Nippon COPD epidemiology (NICE) study. Eur Respir J 2001; 16: Suppl. 31, 1849

Member's Comments

No comment yet.

Related content which might interest you: Economic burdens of patients with chronic obstructive pulmonary disease (COPD) in Japan Source: Eur Respir J 2006; 28: Suppl. 50, 108s Year: 2006 Management of chronic obstructive pulmonary disease (COPD) exacerbations: results of a French cohort study Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD Year: 2008 Treatment patterns of patients with chronic obstructive pulmonary disease (COPD) in Ontario, Canada Source: Virtual Congress 2021 – Inhaled treatments for COPD: real-world data Year: 2021 Prevalence of chronic obstructive pulmonary disease (COPD) in Greece Source: Eur Respir J 2002; 20: Suppl. 38, 122s Year: 2002 Awareness of chronic obstructive pulmonary disease (COPD) in Portugal Source: Eur Respir J 2007; 30: Suppl. 51, 126s Year: 2007 Prevalence of chronic obstructive pulmonary disease (COPD) in a general population in Norway Source: Annual Congress 2012 - COPD epidemiology Year: 2012 Clinical and epidemiological characteristics of chronic obstructive pulmonary disease (COPD) patients in Spain (VICE Study) Source: Eur Respir J 2006; 28: Suppl. 50, 35s Year: 2006 Medical and demographic loss of population due to chronic obstructive pulmonary disease Source: International Congress 2016 – Screening, diagnosis, assessment, and treatment of COPD in primary care Year: 2016 Detection of chronic obstructive pulmonary disease (COPD) in patients with cardio-vascular system pathology Source: Annual Congress 2013 –COPD treatment and others Year: 2013 Exacerbations in chronic obstructive pulmonary disease (COPD) in Ontario, Canada Source: Virtual Congress 2021 – Exacerbations of chronic respiratory diseases, including SARS-CoV-2 Year: 2021 An epidemiological study of chronic obstructive pulmonary disease (COPD) in a rural town of Japan Source: Eur Respir J 2005; 26: Suppl. 49, 593s Year: 2005 Adherence to national (UK) respiratory guidelines in general practice Source: Annual Congress 2007 - Delivering respiratory care: the challenges for primary care Year: 2007 Awareness of chronic obstructive pulmonary disease (COPD) in Portugal general practicioners Source: Eur Respir J 2007; 30: Suppl. 51, 129s Year: 2007 COPD prevalence in Austria: results from the Burden of obstructive lung disease (BOLD) study Source: Eur Respir J 2006; 28: Suppl. 50, 446s Year: 2006 Pulmonary hypertension (PH) in chronic obstructive pulmonary disease (COPD): Preliminary data of a longitudinal survey Source: International Congress 2014 – Clinical presentations Year: 2014 Current maintenance treatment of chronic obstructive pulmonary disease in China Source: International Congress 2014 – Respiratory disease within hospital-based populations Year: 2014 Case control study of chronic obstructive pulmonary disease and its progression Source: Annual Congress 2013 –Genetics and genomics of lung disease Year: 2013 Dietary habits in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2013 –The latest insights in respiratory muscles, neuromuscular disease and comorbidities Year: 2013 Hedgehog-interacting protein is a COPD susceptibility gene: the Rotterdam Study Source: Eur Respir J 2010; 36: 89-95 Year: 2010 The chronic bronchitis phenotype in subjects with and without COPD: the PLATINO study Source: Eur Respir J 2012; 40: 28-36 Year: 2012